CYBERDYNE Inc. (TYO:7779)
174.00
-1.00 (-0.57%)
May 12, 2025, 3:30 PM JST
CYBERDYNE Revenue
CYBERDYNE had revenue of 1.03B JPY in the quarter ending December 31, 2024, a decrease of -7.98%. This brings the company's revenue in the last twelve months to 4.30B, up 4.11% year-over-year. In the fiscal year ending March 31, 2024, CYBERDYNE had annual revenue of 4.35B with 32.38% growth.
Revenue (ttm)
4.30B
Revenue Growth
+4.11%
P/S Ratio
8.54
Revenue / Employee
18.96M
Employees
227
Market Cap
36.74B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 4.35B | 1.07B | 32.38% |
Mar 31, 2023 | 3.29B | 1.14B | 52.98% |
Mar 31, 2022 | 2.15B | 275.00M | 14.67% |
Mar 31, 2021 | 1.88B | 83.00M | 4.63% |
Mar 31, 2020 | 1.79B | 83.00M | 4.86% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 869.37B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 993.33B |